Trials / Completed
CompletedNCT01152229
Platelet Reactivity In Patients With Nuisance Bleeding On A Thienopyridine
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- Medstar Health Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective is to describe and quantify levels of platelet reactivity in three different cohorts of patients taking thienopyridine: patients who report nuisance bleeding, patients who report alarming bleeding, and patients who report no nuisance or alarming bleeding. The investigators hypothesize that patients with nuisance or alarming bleeding events on maintenance thienopyridine therapy will have lower levels of platelet reactivity than patients without nuisance or alarming bleeding on thienopyridine therapy.
Conditions
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2011-06-01
- Completion
- 2011-07-01
- First posted
- 2010-06-29
- Last updated
- 2011-08-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01152229. Inclusion in this directory is not an endorsement.